The Grant for Oncology Innovation (GOI) is an initiative funded by EMD Serono, a business of Merck KGaA, Darmstadt, Germany, to identify and support innovative projects to advance research on personalized treatment for solid tumors.
The grant program was first launched to coincide with the European Cancer Congress (ECCO-ESMO-ESTRO) in Amsterdam, 27 Sept - 1 Oct 2013.
The three winners of the first GOI award were announced during an Award Ceremony that took place in Madrid, Spain on Friday September 26, 2014.
The three winners of the second GOI award were announced during an Award Ceremony that took place in Vienna on Friday September 25, 2015.
The window for submission to the GOI 2016 award has now closed. The website will be updated with the opening date of the 2017 grant following ESMO 2016 congress.